Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Each year, the PM5 program will offer different immunohistochemistry markers to evaluate assay performance on a wide variety of tissues and/or tumor types. The IHC markers for this Survey may change from those listed above due to development constraints.
- Two 10‑core tissue microarray slides, one for pan-TRK and one for Ki-67